Clinical Trial Information
Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma -STRIKE- Protocol Number: A032201
- Status: Open
- Age Group: Adult
- Treatment Type: Treatment
- Phase: III
- NCT ID: NCT06661720
Scope Information
- Scope:
- National
- Disease Site(s):
- Kidney